title: Role of androgen receptor polyQ chain elongation in Kennedy's disease and use of natural osmolytes as potential therapeutic targets.
abstract: Instability of CAG triplet repeat encoding polyglutamine (polyQ) stretches in the gene for target protein has been implicated as a putative mechanism in several inherited neurodegenerative diseases. Expansion of polyQ chain length in the androgen receptor (AR) causes spinal and bulbar muscular atrophy (SBMA) or Kennedy's disease. Although the mechanisms underlying gain-of-neurotoxic function are not completely understood, suggested pathological mechanisms of SBMA involve the formation of AR nuclear and cytoplasmic aggregates, a characteristic feature of patients with SBMA. The fact that certain AR coactivators are sequestered into the nuclear inclusions in SBMA possibly through protein-protein interactions supports the notion that AR transcriptional dysregulation may be a potential pathological mechanism leading to SBMA. AR conformational states associated with aberrant polyQ tract also modulate the interaction of AR with several coactivators. In many cases, such diseases can be treated through protein replacement therapy; however, because recombinant proteins do not cross the blood-brain barrier, the effectiveness of such therapies is limited in case of neurodegenerative diseases that warrant alternative therapeutic approaches. Among different approaches, inhibiting protein aggregation with small molecules that can stimulate protein folding and reverse aggregation are the most promising ones. Thus, naturally occurring osmolytes or "chemical chaperones" that can easily cross the blood-brain barrier and stabilize the functional form of a mutated protein by shifting the folding equilibrium away from degradation and/or aggregation is a useful therapeutic approach. In this review, we discuss the role of polyQ chain length extension in the pathophysiology of SBMA and the use of osmolytes as potential therapeutic tool.
authors.affiliation: Department of Basic Sciences, The Commonwealth Medical College, Scranton, PA 18509, USA. rkumar@tcmedc.org
authors.forename: Raj
authors.initials: R
authors.lastname: Kumar
mesh_terms: D001688:Biological Products / Q000494:pharmacology*; D001812:Blood-Brain Barrier; D055534:Bulbo-Spinal Atrophy, X-Linked / Q000235:genetics / Q000628:therapy*; D006801:Humans; D018832:Molecular Chaperones / Q000494:pharmacology*; D009995:Osmosis; D010455:Peptides / Q000235:genetics*; D011944:Receptors, Androgen / Q000235:genetics*; D019680:Trinucleotide Repeat Expansion / Q000235:genetics*
chemical_list: C410798:AR protein, human; D001688:Biological Products; D018832:Molecular Chaperones; D010455:Peptides; D011944:Receptors, Androgen; C097188:polyglutamine